Compare Novartis AG (NVS) vs Spotify Technology (SPOT) Price & Performance

Novartis AGTrade

Spotify TechnologyTrade

Price performance (Past 24H)

Key statistics

Novartis AG vs Spotify Technology — how do they compare? Novartis AG trades at $152.33 (market cap $295.37B), while Spotify Technology trades at $501.85 (market cap $103.00B). The key difference: Novartis AG is far larger — about 2.9× Spotify Technology's market cap, and Novartis AG pays a 3.07% dividend while Spotify Technology pays none. Which is the better fit depends on your goals.

	NVS	SPOT
Market Cap	$295.37B	$103.00B
Sector	Health	Media
52-Week High	$168.62	$738.53
52-Week Low	$119.31	$412.75
Enterprise Value	$336.69B	$92.70B
Dividend Yield	3.07%	—

View details →View details →

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

NVS

BioCryst hits profitability with strong Q2 revenue, sparking takeover interest in rare disease biotech.24/7 Wall Street · 1 day agoBullish View details →

SPOT

Spotify to label AI-generated music accounts and exclude them from recommendationsNew York Post · 21 hours agoNeutral Spotify labels AI-generated artists with 'AI Persona' tags, excluding them from recommendations.TechCrunch · 1 day agoNeutral View details →

About Novartis AG

Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.

About Spotify Technology

Spotify Technology S.A. provides music streaming services. The Company offers commercial-free music and ad-supported services to subscribers. Spotify Technology serves clients worldwide.